Inflammation has to fight pathogens fast—but it can't get out of control. Researchers at the German Cancer Research Center ...
Sobi® (STO: SOBI), today announced that the European Commission (EC) has approved Aspaveli® (pegcetacoplan) for the treatment of adult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback